• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Medical Tubing and Extrusion

Medical tubing and extrusion technologies

  • Catheters
  • Components
    • Connectors
    • Needles and Injections
    • Seals
    • Tubing Components
  • Manufacturing
    • Coatings
    • Extrusions
    • Machining
    • Injection Molding
    • Insert molding
    • Tools
  • Materials
    • Advanced Materials
    • Silicone
  • Research & Development
  • Suppliers

InTRAvent wins FDA 510(k) clearance for Solopass bedside neuro-navigation device

September 15, 2021 By Jim Hammerand

InTRAvent Solopass
The inTRAvent Solopass (Photo courtesy of inTRAvent)

InTRAvent has announced FDA 510(k) clearance of its Solopass system for assisting frontal placement of intraventricular catheters deep within the brain.

The Hershey, Pennsylvania-based company said yesterday that it designed the device with 2D and 3D ultrasound imaging, artificial intelligence and trajectory guidance for intraprocedural localization and navigation for external ventricular drain (EVD) placement.

“Early on in my career, I lost a patient I was caring for as a result of EVD complications,” inTRAvent co-founder and Chief Medical Officer Dr. Will Hazard said in a news release. “Our aim has always been to advance the standard of care for this all-too-common, unsolved problem.”

EVD placements are among the most common life-saving procedures in neurointensive care, the company said, but although neuro-navigation is routinely used in neurosurgical operating rooms, bedside EVD catheter procedures in the ICU and ER rely on surface landmarks and the physician’s experience with and knowledge of the brain’s anatomy. Bedside EVD placement can be especially challenging when the intricate intracranial anatomy is distorted (known as “brain shift”) due to excess cerebrospinal fluid, traumatic brain injury, cerebral edema or other conditions that dangerously increase pressure in the skull.

“Solopass represents a significant advancement in the treatment of these critically ill patients, and we believe it can potentially reduce downstream healthcare costs associated with lengthy stays in the ICU,” inTRAvent co-founder and CEO Adam Barner said in the news release.

Filed Under: Catheters Tagged With: inTRAvent

Primary Sidebar

DeviceTalks Tuesdays

DeviceTalks Tuesdays
MDO ad

Stay Current

Need Medical Tubing news in a minute?
We Deliver!

Medical Tubing + Extrusion newsletter get you caught up on all the mission critical news you need in medical tubing. Sign up today.

Enews Sign up

Sponsored Content

A new way to access scientific papers?

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website

Footer

Inv Logo

MASSDEVICE MEDICAL NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

Medical Tubing & Extrusion

Subscribe to our e-newsletter
Advertise with us
About
Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS